Dr. Kozan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
757 Westwood Plz
Los Angeles, CA 90095Phone+1 909-631-3130
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Gastroenterology, 2019 - 2025- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 2020 - 2022
- UCLA David Geffen School of Medicine/UCLA Medical CenterInternship, Internal Medicine, 2019 - 2020
Albert Einstein College of MedicineClass of 2019
Certifications & Licensure
CA State Medical License 2022 - 2026- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 2 citationsPneumococcal Vaccination Recommendation and Completion Rates Among Patients With Inflammatory Bowel Disease and Barriers to Vaccination.Sonya S Dasharathy, Folasade P May, Anthony Myint, Liu Yang, Harman K Rahal
Journal of Clinical Gastroenterology. 2023-01-19 - 37 citationsMutation of EpCAM leads to intestinal barrier and ion transport dysfunctionPhilip Kozan, Matthew D. McGeough, Carla A. Peña, James L. Mueller, Kim E. Barrett
Journal of Molecular Medicine. 2015-05-01 - 1 citationsPatient-Preferences Favoring Treatment Discontinuation Are Reduced With Vedolizumab and Ustekinumab Compared With TNF Antagonists in Inflammatory Bowel Disease.Anand Kumar, Emilie S Kim, Philip Kozan, Vinita Jacob, Randy S Longman
Crohn's & Colitis 360. 2020-10-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
